Literature DB >> 16001594

A humanitarian mission in southern Iraq: utilization of the 7th Field Hospital of the Army of the Czech Republic--a report on its medical activities and working conditions.

Petr Chmátal1, Milos Bohonĕk, Martina Dobiásová, Robert Hasek, Miroslav Cernohous.   

Abstract

Between April 24 and September 18, 2003, a total of 7,099 outpatient treatments were performed. Between June 3 and September 18, 2003, a total of 124 patients were surgically treated and 209 patients were hospitalized; the hospital recorded 1,239 bed-days, 137 of them in the intensive care unit. A total of 924 X-ray and ultrasound examinations were performed, as well as 10,014 laboratory tests. Local inhabitants accounted for 90.5% of the patients. In their practice, the doctors encountered a very wide spectrum of surgical and nonsurgical diagnoses. Part of the work was to support humanitarian activities, with supplies of humanitarian material, selection of children for specialized cardiosurgical treatment in the Czech Republic, and blood donations. Work in that unstable region was significantly complicated by the extreme climate and the high security risk.

Entities:  

Mesh:

Year:  2005        PMID: 16001594     DOI: 10.7205/milmed.170.6.473

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  Prediction of unmet primary care needs for the medically vulnerable post-disaster: an interrupted time-series analysis of health system responses.

Authors:  Jennifer D Runkle; Hongmei Zhang; Wilfried Karmaus; Amy B Martin; Erik R Svendsen
Journal:  Int J Environ Res Public Health       Date:  2012-09-25       Impact factor: 3.390

2.  Anesthesia during deployment of a military forward surgical unit in low income countries: A register study of 1547 anesthesia cases.

Authors:  Quentin Mathais; Ambroise Montcriol; Jean Cotte; Céline Gil; Claire Contargyris; Guillaume Lacroix; Bertrand Prunet; Julien Bordes; Eric Meaudre
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.